Personalised Cancer Plan
Make treatment decisions with greater confidence
Precision insights that complement standard oncology care to support next-step planning, biomarker evaluation, and ongoing monitoring discussions with your healthcare team.
Key Studies and Clinical References
Selected studies and institutional references related to precision oncology, molecular profiling, biomarker-guided treatment strategies, liquid biopsy, and tumour-informed clinical decision support.
Tsimberidou et al.
About: Personalized medicine outcomes in advanced cancer patients treated within the MD Anderson phase I program.
Findings: Matched treatment approaches were reported alongside differences in clinical outcome patterns in selected patients.
Von Hoff et al.
About: Molecular profiling used to support therapy selection in metastatic cancer.
Findings: Tumour profiling was explored as a tool to support individualized treatment planning in refractory disease.
Alix-Panabières & Pantel
About: Clinical relevance of circulating tumour cells and circulating tumour DNA.
Findings: Liquid biopsy technologies may provide additional information for tumour characterization and monitoring.
Herzog et al.
About: ChemoID-guided therapy in platinum-resistant ovarian cancer.
Findings: Therapy guidance based on tumour-related testing was evaluated as a potential aid in resistant disease management.
Lindeman et al.
About: Updated molecular testing guideline for lung cancer.
Findings: Molecular testing was highlighted as an important component of treatment decision-making in selected lung cancer settings.
Ross et al.
About: Comprehensive genomic profiling in lung cancer.
Findings: Genomic profiling identified biologically relevant alterations that may support further clinical evaluation.
MD Anderson Cancer Center
About: Institutional precision medicine program outcomes in advanced cancer.
Findings: Program data described how molecular matching strategies were being explored within oncology care pathways.
MD Anderson Cancer Center
About: Molecular profiling initiative supporting individualized oncology assessment.
Findings: The framework highlighted how tumour profiling could contribute additional information for clinical evaluation.
UC San Diego Moores Cancer Center
About: Molecular profiling and clinical outcome evaluation.
Findings: The study explored possible relationships between tumour profiling and clinical outcome trends.
UC San Diego Moores Cancer Center
About: Real-world molecular tumour board data in breast and gynecologic cancers.
Findings: Tumour board discussions may provide additional context regarding the use of profiling information in clinical practice.
National Cancer Institute
About: Molecular Analysis for Therapy Choice in pediatric oncology.
Findings: The trial evaluated whether molecular findings could support targeted therapy selection in pediatric cancer.
Precision Oncology Survival Outcomes
About: Survival outcomes in selected late-stage cancer populations.
Findings: Outcome differences were summarized across selected precision oncology settings.
Precision Medicine in Lung Cancer
About: Clinical benefit analysis in lung cancer precision medicine.
Findings: The report summarized how precision-based approaches may contribute additional clinical insight.
Impact of Precision Medicine on Clinical Outcomes
About: Evaluation of how precision medicine may influence oncology outcomes.
Findings: The report outlined observed outcome patterns associated with biologically informed care planning.
Are you starting your Chemo?
Get a free 15 min discussion with our expert
Empower yourself with knowledge about precision medicine!
Contact Us
Contact Us for the updated information on Precision Medicine
+852 4750 3485
Email Us
info@mycancerinfo.org